---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-25-000009"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:02:39.524453+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Q4 revenue $239.7M (+25% YoY); EPS $1.15; guides FY2025 rev $940-955M

## Summary
- Q4 revenue $239.7M (+25% YoY); net income $35.2M, diluted EPS $1.15 vs $0.49 prior year.
- Full year 2024 revenue $802.8M (+28% YoY); net income $53.5M ($1.75 diluted EPS) vs net loss in 2023.
- FY2025 guidance: revenue $940-955M (17-19% growth); diluted EPS $2.10-$2.20.
- Added 72 U.S. centers in Q4 (total 1,435); U.S. sales territories now 335; over 90,000 patients treated.
- Initiated $75M accelerated share repurchase program; operating cash flow $130.2M for full year.

## SEC filing metadata
- accession: 0001609550-25-000009
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000009/0001609550-25-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000009/insp-20250210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-25-000009
- JSON: https://secwatch.observer/filing/0001609550-25-000009.json
- Plain text: https://secwatch.observer/filing/0001609550-25-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.